Perram, J., Purtill, D., Bajel, A., Butler, J., O'Brien, T., Teh, B., Gilroy, N., Ho, P. J., Doocey, R., Hills, T., Perera, T., Douglas, G., Ramachandran, S., Chee, L., Trotman, J., Weinkove, R., Keogh, S., Fraser, C., Cochrane, T., Watson, A., Diamond, P., Latimer, M., Irving, I., Blyth, E., Cheah, C., Cole, T., Milliken, S., Yang, H., Greenwood, M., Bardy, P., Kennedy, G., Larsen, S., Conyers, R., & Hamad, N. (2023). australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell. Internal medicine journal, 53(1), 119–125. http://access.bl.uk/ark:/81055/vdc_100174903980.0x00001a